Ideal age for measles vaccination with persisting maternal antibody, human immunodeficiency virus infection and protein-calorie malnutrition

This publication has 18 references indexed in Scilit:

• Increased Risk of Early Measles in Infants of Human Immunodeficiency Virus Type 1-Seropositive Mothers
  The Journal of Infectious Diseases, 1992
• Evaluation of measles vaccination programme conducted in two separate health centres
  Vaccine, 1992
• Child mortality after high-titre measles vaccines: prospective study in Senegal
  The Lancet, 1991
• Loss of Maternal Measles Antibody during Infancy in an African City
  International Journal of Epidemiology, 1989
• TRIAL OF HIGH-DOSE EDMONSTON-ZAGREB MEASLES VACCINE IN THE GAMBIA: ANTIBODY RESPONSE AND SIDE-EFFECTS
  The Lancet, 1988
• Maternally derived measles immunity in children of naturally infected and vaccinated mothers
  Epidemiology and Infection, 1988
• Response to Measles Vaccine in Haitian Infants 6 to 12 Months Old
  New England Journal of Medicine, 1985
• Nutritional Regulation of Host Resistance and Predictive Value of Immunologic Tests in Assessment of Outcome
  Pediatric Clinics of North America, 1985
• Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failure
  The Journal of Pediatrics, 1977
• Inadequate Poliovirus Immunity Levels in Immunized Illinois Children
  Archives of Pediatrics & Adolescent Medicine, 1973